Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1992 Jul;76(3):349–354.

Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.

A Tärnvik, M Eriksson, G Sandström, A Sjöstedt
PMCID: PMC1421695  PMID: 1526645

Full text

PDF
351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALEXANDER M. M., WRIGHT G. G., BALDWIN A. C. Observations on the agglutination of polysaccharide-treated erythrocytes by tularemia antisera. J Exp Med. 1950 Jun 1;91(6):561–566. doi: 10.1084/jem.91.6.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ALLEN W. P. Immunity against tularemia: passive protection of mice by transfer of immune tissues. J Exp Med. 1962 Feb 1;115:411–420. doi: 10.1084/jem.115.2.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Abou-Zeid C., Filley E., Steele J., Rook G. A. A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen-bearing particles. J Immunol Methods. 1987 Apr 2;98(1):5–10. doi: 10.1016/0022-1759(87)90429-7. [DOI] [PubMed] [Google Scholar]
  4. Anthony L. S., Ghadirian E., Nestel F. P., Kongshavn P. A. The requirement for gamma interferon in resistance of mice to experimental tularemia. Microb Pathog. 1989 Dec;7(6):421–428. doi: 10.1016/0882-4010(89)90022-3. [DOI] [PubMed] [Google Scholar]
  5. Anthony L. S., Kongshavn P. A. Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance. Microb Pathog. 1987 Jan;2(1):3–14. doi: 10.1016/0882-4010(87)90110-0. [DOI] [PubMed] [Google Scholar]
  6. Anthony L. S., Kongshavn P. A. H-2 restriction in acquired cell-mediated immunity to infection with Francisella tularensis LVS. Infect Immun. 1988 Feb;56(2):452–456. doi: 10.1128/iai.56.2.452-456.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Austrian R., Douglas R. M., Schiffman G., Coetzee A. M., Koornhof H. J., Hayden-Smith S., Reid R. D. Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians. 1976;89:184–194. [PubMed] [Google Scholar]
  8. Banerjee D. K., Sharp A. K., Lowrie D. B. The effect of gamma-interferon during Mycobacterium bovis (BCG) infection in athymic and euthymic mice. Microb Pathog. 1986 Apr;1(2):221–224. doi: 10.1016/0882-4010(86)90024-0. [DOI] [PubMed] [Google Scholar]
  9. Barnes P. F., Mehra V., Hirschfield G. R., Fong S. J., Abou-Zeid C., Rook G. A., Hunter S. W., Brennan P. J., Modlin R. L. Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis. J Immunol. 1989 Oct 15;143(8):2656–2662. [PubMed] [Google Scholar]
  10. Bhardwaj N., Nash T. W., Horwitz M. A. Interferon-gamma-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila. J Immunol. 1986 Oct 15;137(8):2662–2669. [PubMed] [Google Scholar]
  11. Blander S. J., Horwitz M. A. Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. J Exp Med. 1989 Mar 1;169(3):691–705. doi: 10.1084/jem.169.3.691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Brooks-Alder B., Splitter G. A. Determination of bovine lymphocyte responses to extracted proteins of Brucella abortus by using protein immunoblotting. Infect Immun. 1988 Oct;56(10):2581–2586. doi: 10.1128/iai.56.10.2581-2586.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Burke D. S. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis. 1977 Jan;135(1):55–60. doi: 10.1093/infdis/135.1.55. [DOI] [PubMed] [Google Scholar]
  14. Claflin J. L., Larson C. L. Infection-immunity in tularemia: specificity of cellular immunity. Infect Immun. 1972 Mar;5(3):311–318. doi: 10.1128/iai.5.3.311-318.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Clerici M., Stocks N. I., Zajac R. A., Boswell R. N., Bernstein D. C., Mann D. L., Shearer G. M., Berzofsky J. A. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature. 1989 Jun 1;339(6223):383–385. doi: 10.1038/339383a0. [DOI] [PubMed] [Google Scholar]
  16. Converse P. J., Ottenhoff T. H., Gebre N., Ehrenberg J. P., Kiessling R. Cellular, humoral, and gamma interferon responses to Mycobacterium leprae and BCG antigens in healthy individuals exposed to leprosy. Scand J Immunol. 1988 May;27(5):515–525. doi: 10.1111/j.1365-3083.1988.tb02378.x. [DOI] [PubMed] [Google Scholar]
  17. Crowle A. J. Immunization against tuberculosis: what kind of vaccine? Infect Immun. 1988 Nov;56(11):2769–2773. doi: 10.1128/iai.56.11.2769-2773.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. DeLisi C., Berzofsky J. A. T-cell antigenic sites tend to be amphipathic structures. Proc Natl Acad Sci U S A. 1985 Oct;82(20):7048–7052. doi: 10.1073/pnas.82.20.7048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Deepe G. S., Jr, Brunner G. D. Functional analysis of Histoplasma capsulatum-reactive T-cell hybridomas. Infect Immun. 1990 Jun;58(6):1538–1544. doi: 10.1128/iai.58.6.1538-1544.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Del Prete G. F., De Carli M., Mastromauro C., Biagiotti R., Macchia D., Falagiani P., Ricci M., Romagnani S. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest. 1991 Jul;88(1):346–350. doi: 10.1172/JCI115300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Emmrich F., Kaufmann S. H. Human T-cell clones with reactivity to Mycobacterium leprae as tools for the characterization of potential vaccines against leprosy. Infect Immun. 1986 Mar;51(3):879–883. doi: 10.1128/iai.51.3.879-883.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Etlinger H. M., Gillessen D., Lahm H. W., Matile H., Schönfeld H. J., Trzeciak A. Use of prior vaccinations for the development of new vaccines. Science. 1990 Jul 27;249(4967):423–425. doi: 10.1126/science.1696030. [DOI] [PubMed] [Google Scholar]
  23. Falk K., Rötzschke O., Rammensee H. G. Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature. 1990 Nov 15;348(6298):248–251. doi: 10.1038/348248a0. [DOI] [PubMed] [Google Scholar]
  24. Falk K., Rötzschke O., Stevanović S., Jung G., Rammensee H. G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 1991 May 23;351(6324):290–296. doi: 10.1038/351290a0. [DOI] [PubMed] [Google Scholar]
  25. Falla J. C., Parra C. A., Mendoza M., Franco L. C., Guzmán F., Forero J., Orozco O., Patarroyo M. E. Identification of B- and T-cell epitopes within the MTP40 protein of Mycobacterium tuberculosis and their correlation with the disease course. Infect Immun. 1991 Jul;59(7):2265–2273. doi: 10.1128/iai.59.7.2265-2273.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Gotschlich E. C., Goldschneider I., Artenstein M. S. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med. 1969 Jun 1;129(6):1367–1384. doi: 10.1084/jem.129.6.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Haanen J. B., de Waal Malefijt R., Res P. C., Kraakman E. M., Ottenhoff T. H., de Vries R. R., Spits H. Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med. 1991 Sep 1;174(3):583–592. doi: 10.1084/jem.174.3.583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hahn H., Kaufmann S. H. The role of cell-mediated immunity in bacterial infections. Rev Infect Dis. 1981 Nov-Dec;3(6):1221–1250. doi: 10.1093/clinids/3.6.1221. [DOI] [PubMed] [Google Scholar]
  29. Harris D. P., Bäckström B. T., Booth R. J., Love S. G., Harding D. R., Watson J. D. The mapping of epitopes of the 18-kDa protein of Mycobacterium leprae recognized by murine T cells in a proliferation assay. J Immunol. 1989 Sep 15;143(6):2006–2012. [PubMed] [Google Scholar]
  30. Hoffman S. L., Berzofsky J. A., Isenbarger D., Zeltser E., Majarian W. R., Gross M., Ballou W. R. Immune response gene regulation of immunity to Plasmodium berghei sporozoites and circumsporozoite protein vaccines. Overcoming genetic restriction with whole organism and subunit vaccines. J Immunol. 1989 May 15;142(10):3581–3584. [PubMed] [Google Scholar]
  31. Karttunen R., Andersson G., Ekre H. P., Juutinen K., Surcel H. M., Syrjälä H., Herva E. Interleukin 2 and gamma interferon production, interleukin 2 receptor expression, and DNA synthesis induced by tularemia antigen in vitro after natural infection or vaccination. J Clin Microbiol. 1987 Jun;25(6):1074–1078. doi: 10.1128/jcm.25.6.1074-1078.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Karttunen R., Ilonen J., Herva E. Interleukin 2 production in whole blood culture: a rapid test of immunity to Francisella tularensis. J Clin Microbiol. 1985 Aug;22(2):318–319. doi: 10.1128/jcm.22.2.318-319.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kaufmann S. H. CD8+ T lymphocytes in intracellular microbial infections. Immunol Today. 1988 Jun;9(6):168–174. doi: 10.1016/0167-5699(88)91292-3. [DOI] [PubMed] [Google Scholar]
  34. Kees U., Krammer P. H. Most influenza A virus-specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants. J Exp Med. 1984 Feb 1;159(2):365–377. doi: 10.1084/jem.159.2.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Kiderlen A. F., Kaufmann S. H., Lohmann-Matthes M. L. Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur J Immunol. 1984 Oct;14(10):964–967. doi: 10.1002/eji.1830141019. [DOI] [PubMed] [Google Scholar]
  36. Koskela P., Herva E. Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine. Infect Immun. 1982 Jun;36(3):983–989. doi: 10.1128/iai.36.3.983-989.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Koskela P., Herva E. Cell-mediated immunity against Francisella tularensis after natural infection. Scand J Infect Dis. 1980;12(4):281–287. doi: 10.3109/inf.1980.12.issue-4.08. [DOI] [PubMed] [Google Scholar]
  38. Koskela P., Herva E. Immunity against Francisella tularensis in northern Finland. Scand J Infect Dis. 1982;14(3):195–199. doi: 10.3109/inf.1982.14.issue-3.07. [DOI] [PubMed] [Google Scholar]
  39. Kostiala A. A., McGregor D. D., Logie P. S. Tularaemia in the rat. I. The cellular basis on host resistance to infection. Immunology. 1975 May;28(5):855–869. [PMC free article] [PubMed] [Google Scholar]
  40. Lamb J. R., Lathigra R., Rothbard J. B., Sweetser D., Young R. A., Ivanyi J., Young D. B. Identification of mycobacterial antigens recognized by T lymphocytes. Rev Infect Dis. 1989 Mar-Apr;11 (Suppl 2):S443–S447. doi: 10.1093/clinids/11.supplement_2.s443. [DOI] [PubMed] [Google Scholar]
  41. Lamb J. R., Young D. B. A novel approach to the identification of T-cell epitopes in Mycobacterium tuberculosis using human T-lymphocyte clones. Immunology. 1987 Jan;60(1):1–5. [PMC free article] [PubMed] [Google Scholar]
  42. Lee S. P., Stoker N. G., Grant K. A., Handzel Z. T., Hussain R., McAdam K. P., Dockrell H. M. Cellular immune responses of leprosy contacts to fractionated Mycobacterium leprae antigens. Infect Immun. 1989 Aug;57(8):2475–2480. doi: 10.1128/iai.57.8.2475-2480.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Löfgren S., Tärnvik A., Bloom G. D., Sjöberg W. Phagocytosis and killing of Francisella tularensis by human polymorphonuclear leukocytes. Infect Immun. 1983 Feb;39(2):715–720. doi: 10.1128/iai.39.2.715-720.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Löfgren S., Tärnvik A., Thore M., Carlsson J. A wild and an attenuated strain of Francisella tularensis differ in susceptibility to hypochlorous acid: a possible explanation of their different handling by polymorphonuclear leukocytes. Infect Immun. 1984 Feb;43(2):730–734. doi: 10.1128/iai.43.2.730-734.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Mehra V., Bloom B. R., Torigian V. K., Mandich D., Reichel M., Young S. M., Salgame P., Convit J., Hunter S. W., McNeil M. Characterization of Mycobacterium leprae cell wall-associated proteins with the use of T lymphocyte clones. J Immunol. 1989 Apr 15;142(8):2873–2878. [PubMed] [Google Scholar]
  46. Melby P. C., Neva F. A., Sacks D. L. Profile of human T cell response to leishmanial antigens. Analysis by immunoblotting. J Clin Invest. 1989 Jun;83(6):1868–1875. doi: 10.1172/JCI114093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Melby P. C., Sacks D. L. Identification of antigens recognized by T cells in human leishmaniasis: analysis of T-cell clones by immunoblotting. Infect Immun. 1989 Oct;57(10):2971–2976. doi: 10.1128/iai.57.10.2971-2976.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Mendez-Samperio P., Lamb J., Bothamley G., Stanley P., Ellis C., Ivanyi J. Molecular study of the T cell repertoire in family contacts and patients with leprosy. J Immunol. 1989 May 15;142(10):3599–3604. [PubMed] [Google Scholar]
  49. Mosmann T. R., Coffman R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–173. doi: 10.1146/annurev.iy.07.040189.001045. [DOI] [PubMed] [Google Scholar]
  50. Nutter J. E., Myrvik Q. N. In vitro interactions between rabbit alveolar macrophages and Pasteurella tularensis. J Bacteriol. 1966 Sep;92(3):645–651. doi: 10.1128/jb.92.3.645-651.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Oftung F., Mustafa A. S., Shinnick T. M., Houghten R. A., Kvalheim G., Degre M., Lundin K. E., Godal T. Epitopes of the Mycobacterium tuberculosis 65-kilodalton protein antigen as recognized by human T cells. J Immunol. 1988 Oct 15;141(8):2749–2754. [PubMed] [Google Scholar]
  52. Orme I. M. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect Immun. 1988 Dec;56(12):3310–3312. doi: 10.1128/iai.56.12.3310-3312.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Pamer E. G., Harty J. T., Bevan M. J. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature. 1991 Oct 31;353(6347):852–855. doi: 10.1038/353852a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Rothbard J. B., Lechler R. I., Howland K., Bal V., Eckels D. D., Sekaly R., Long E. O., Taylor W. R., Lamb J. R. Structural model of HLA-DR1 restricted T cell antigen recognition. Cell. 1988 Feb 26;52(4):515–523. doi: 10.1016/0092-8674(88)90464-3. [DOI] [PubMed] [Google Scholar]
  55. Rouse B. T., Norley S., Martin S. Antiviral cytotoxic T lymphocyte induction and vaccination. Rev Infect Dis. 1988 Jan-Feb;10(1):16–33. doi: 10.1093/clinids/10.1.16. [DOI] [PubMed] [Google Scholar]
  56. Rudensky AYu, Preston-Hurlburt P., Hong S. C., Barlow A., Janeway C. A., Jr Sequence analysis of peptides bound to MHC class II molecules. Nature. 1991 Oct 17;353(6345):622–627. doi: 10.1038/353622a0. [DOI] [PubMed] [Google Scholar]
  57. SASLAW S., EIGELSBACH H. T., WILSON H. E., PRIOR J. A., CARHART S. Tularemia vaccine study. I. Intracutaneous challenge. Arch Intern Med. 1961 May;107:689–701. doi: 10.1001/archinte.1961.03620050055006. [DOI] [PubMed] [Google Scholar]
  58. Sandström G., Löfgren S., Tärnvik A. A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect Immun. 1988 May;56(5):1194–1202. doi: 10.1128/iai.56.5.1194-1202.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Sandström G., Tärnvik A., Wolf-Watz H. Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis. J Clin Microbiol. 1987 Apr;25(4):641–644. doi: 10.1128/jcm.25.4.641-644.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Sandström G., Tärnvik A., Wolf-Watz H., Löfgren S. Antigen from Francisella tularensis: nonidentity between determinants participating in cell-mediated and humoral reactions. Infect Immun. 1984 Jul;45(1):101–106. doi: 10.1128/iai.45.1.101-106.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Sette A., Lamont A., Buus S., Colon S. M., Miles C., Grey H. M. Effect of conformational propensity of peptide antigens in their interaction with MHC class II molecules. Failure to document the importance of regular secondary structures. J Immunol. 1989 Aug 15;143(4):1268–1273. [PubMed] [Google Scholar]
  62. Sinigaglia F., Guttinger M., Kilgus J., Doran D. M., Matile H., Etlinger H., Trzeciak A., Gillessen D., Pink J. R. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature. 1988 Dec 22;336(6201):778–780. doi: 10.1038/336778a0. [DOI] [PubMed] [Google Scholar]
  63. Sjöstedt A., Sandström G., Tärnvik A. Immunization of mice with an attenuated Salmonella typhimurium strain expressing a membrane protein of Francisella tularensis. A model for identification of bacterial determinants relevant to the host defence against tularemia. Res Microbiol. 1990 Sep-Oct;141(7-8):887–891. doi: 10.1016/0923-2508(90)90126-b. [DOI] [PubMed] [Google Scholar]
  64. Sjöstedt A., Sandström G., Tärnvik A., Jaurin B. Molecular cloning and expression of a T-cell stimulating membrane protein of Francisella tularensis. Microb Pathog. 1989 Jun;6(6):403–414. doi: 10.1016/0882-4010(89)90082-x. [DOI] [PubMed] [Google Scholar]
  65. Sjöstedt A., Sandström G., Tärnvik A., Jaurin B. Nucleotide sequence and T cell epitopes of a membrane protein of Francisella tularensis. J Immunol. 1990 Jul 1;145(1):311–317. [PubMed] [Google Scholar]
  66. Sjöstedt A., Sandström G., Tärnvik A. Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals. J Clin Microbiol. 1990 Jan;28(1):43–48. doi: 10.1128/jcm.28.1.43-48.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Sjöstedt A., Tärnvik A., Sandström G. The T-cell-stimulating 17-kilodalton protein of Francisella tularensis LVS is a lipoprotein. Infect Immun. 1991 Sep;59(9):3163–3168. doi: 10.1128/iai.59.9.3163-3168.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Spouge J. L., Guy H. R., Cornette J. L., Margalit H., Cease K., Berzofsky J. A., DeLisi C. Strong conformational propensities enhance T cell antigenicity. J Immunol. 1987 Jan 1;138(1):204–212. [PubMed] [Google Scholar]
  69. Surcel H. M. Diversity of Francisella tularensis antigens recognized by human T lymphocytes. Infect Immun. 1990 Aug;58(8):2664–2668. doi: 10.1128/iai.58.8.2664-2668.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Surcel H. M., Ilonen J., Poikonen K., Herva E. Francisella tularensis-specific T-cell clones are human leukocyte antigen class II restricted, secrete interleukin-2 and gamma interferon, and induce immunoglobulin production. Infect Immun. 1989 Sep;57(9):2906–2908. doi: 10.1128/iai.57.9.2906-2908.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Surcel H. M., Sarvas M., Helander I. M., Herva E. Membrane proteins of Francisella tularensis LVS differ in ability to induce proliferation of lymphocytes from tularemia-vaccinated individuals. Microb Pathog. 1989 Dec;7(6):411–419. doi: 10.1016/0882-4010(89)90021-1. [DOI] [PubMed] [Google Scholar]
  72. Surcel H. M., Syrjälä H., Karttunen R., Tapaninaho S., Herva E. Development of Francisella tularensis antigen responses measured as T-lymphocyte proliferation and cytokine production (tumor necrosis factor alpha, gamma interferon, and interleukin-2 and -4) during human tularemia. Infect Immun. 1991 Jun;59(6):1948–1953. doi: 10.1128/iai.59.6.1948-1953.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Syrjälä H., Herva E., Ilonen J., Saukkonen K., Salminen A. A whole-blood lymphocyte stimulation test for the diagnosis of human tularemia. J Infect Dis. 1984 Dec;150(6):912–915. doi: 10.1093/infdis/150.6.912. [DOI] [PubMed] [Google Scholar]
  74. TIGERTT W. D. Soviet viable Pasteurella tularensis vaccines. A review of selected articles. Bacteriol Rev. 1962 Sep;26:354–373. doi: 10.1128/br.26.3.354-373.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Tärnvik A., Holm S. E. Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis. Infect Immun. 1978 Jun;20(3):698–704. doi: 10.1128/iai.20.3.698-704.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Tärnvik A., Löfgren M. L., Löfgren S., Sandström G., Wolf-Watz H. Long-lasting cell-mediated immunity induced by a live Francisella tularensis vaccine. J Clin Microbiol. 1985 Oct;22(4):527–530. doi: 10.1128/jcm.22.4.527-530.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Tärnvik A., Löfgren S. Stimulation of human lymphocytes by a vaccine strain of Francisella tularensis. Infect Immun. 1975 Nov;12(5):951–957. doi: 10.1128/iai.12.5.951-957.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Tärnvik A. Nature of protective immunity to Francisella tularensis. Rev Infect Dis. 1989 May-Jun;11(3):440–451. [PubMed] [Google Scholar]
  79. Tärnvik A., Sandström G., Löfgren S. Time of lymphocyte response after onset of tularemia and after tularemia vaccination. J Clin Microbiol. 1979 Dec;10(6):854–860. doi: 10.1128/jcm.10.6.854-860.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Van Schooten W. C., Elferink D. G., Van Embden J., Anderson D. C., De Vries R. R. DR3-restricted T cells from different HLA-DR3-positive individuals recognize the same peptide (amino acids 2-12) of the mycobacterial 65-kDa heat-shock protein. Eur J Immunol. 1989 Nov;19(11):2075–2079. doi: 10.1002/eji.1830191116. [DOI] [PubMed] [Google Scholar]
  81. WRIGHT G. G., FEINBERG R. J. Hemagglutination by tularemia antisera: further observations on agglutination of polysaccharide-treated erythrocytes and its inhibition by polysaccharide. J Immunol. 1952 Jan;68(1):65–71. [PubMed] [Google Scholar]
  82. Wentworth P. A., Ziegler H. K. The antigenic and mitogenic response of murine T and B lymphocytes to soluble proteins of Listeria monocytogenes. J Immunol. 1987 Apr 15;138(8):2671–2678. [PubMed] [Google Scholar]
  83. Wiegeshaus E., Balasubramanian V., Smith D. W. Immunity to tuberculosis from the perspective of pathogenesis. Infect Immun. 1989 Dec;57(12):3671–3676. doi: 10.1128/iai.57.12.3671-3676.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Wierenga E. A., Snoek M., de Groot C., Chrétien I., Bos J. D., Jansen H. M., Kapsenberg M. L. Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J Immunol. 1990 Jun 15;144(12):4651–4656. [PubMed] [Google Scholar]
  85. Young D. B., Lamb J. R. T lymphocytes respond to solid-phase antigen: a novel approach to the molecular analysis of cellular immunity. Immunology. 1986 Oct;59(2):167–171. [PMC free article] [PubMed] [Google Scholar]
  86. von Koenig C. H., Finger H., Hof H. Failure of killed Listeria monocytogenes vaccine to produce protective immunity. Nature. 1982 May 20;297(5863):233–234. doi: 10.1038/297233a0. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES